A live webcast can be accessed under “Events & Presentations” in the Investors section of the company’s website at www.agios.com.
CAMBRIDGE, Mass., Oct. 25, 2017 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced that the company will host a conference call and live webcast on Wednesday, November 1, 2017 at 8:00 a.m. ET to report its third quarter 2017 financial results and discuss recent clinical development and corporate activities.
A live webcast can be accessed under “Events & Presentations” in the Investors section of the company’s website at www.agios.com. The conference call can be accessed by dialing 1-877-377-7098 (domestic) or 1-631-291-4547 (international) and referring to conference ID 99771605. The webcast will be archived and made available for replay on the company’s website beginning approximately two hours after the event.
About Agios
Agios is focused on discovering and developing novel investigational medicines to treat cancer and rare genetic diseases through scientific leadership in the field of cellular metabolism. In addition to an active research and discovery pipeline across both therapeutic areas, Agios has an approved oncology precision medicine and multiple first-in-class investigational therapies in clinical and/or preclinical development. All Agios programs focus on genetically identified patient populations, leveraging our knowledge of metabolism, biology and genomics. For more information, please visit the company’s website at www.agios.com.
Agios Pharmaceuticals: Renee Leck, 617-649-8299 Senior Manager, Investor & Public Relations Renee.Leck@agios.com
